Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

NAUTNAUT
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in NAUTILUS BIOTECHNOLOGY INC

Yes. JPMorgan Chase holds 614,177 shares of NAUT (Nautilus Biotechnology), worth $1.1M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.

Current Value

$1.1M

Current Shares

614,177

Total Value Change

+$997,908

Total Shares Change

+578,574

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
614,177
-
$1.1M0.0%$1.87
35
2025-Q4
Exited
0
-100.0%
$00.0%$1.95
0
2025-Q3
Decreased
2,121
-8.8%
$1,7920.0%$0.85
0
2025-Q2
Decreased
2,327
-96.4%
$1,6870.0%$0.73
0
2025-Q1
Decreased
64,836
-55.6%
$55,8230.0%$0.86
0
2024-Q4
Increased
145,937
+309.9%
$245,1730.0%$1.68
25
2024-Q3
First report
35,603
-
$101,4690.0%$2.85
0

Other major holders of NAUT: RA CAPITAL MANAGEMENT, L.P., Alyeska Investment Group, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used